Skip to main content
Clinical Trials/NCT03419273
NCT03419273
Completed
Not Applicable

Adipose Tissue Inflammation in Individuals Undergoing Bariatric Surgery

University of Missouri-Columbia1 site in 1 country84 target enrollmentJuly 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity, Morbid
Sponsor
University of Missouri-Columbia
Enrollment
84
Locations
1
Primary Endpoint
TNFa
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

A growing body of work done over the past few decades has established that adipose tissue as an active endocrine organ which secretes a wide range of metabolic and immunological factors collectively called "adipokines (1)." Importantly, these secreted factors enter into the circulation and have paracrine and autocrine actions, which profoundly impact systemic metabolism (e.g., insulin sensitivity). Additionally, in animals, loss of ovarian hormone production via ovariectomy (similar to menopause in humans) leads to increases in both in adipose tissue mass and in adipose tissue inflammation (2) making this tissue less healthy than that from premenopausal animals. To date, no studies have investigated the effect of menopause on abdominal fat in overweight individuals. Knowing if adipose tissue-specific changes occur with menopause may potentially lead to recommendations or therapeutics to improve women's health post menopause.

Detailed Description

Subjects will just have to agree to having a small amount of adipose tissue being removed during the bariatric surgery. The investigators will also collect a blood sample at that time. There will be no other visits for the subject.

Registry
clinicaltrials.gov
Start Date
July 1, 2017
End Date
July 1, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jill Kanaley

professor

University of Missouri-Columbia

Eligibility Criteria

Inclusion Criteria

  • Women who are premenopausal or who are postmenopausal and have been for at least one year.
  • Males will be recruited to age match female subjects. All subject are already scheduled to have bariatric surgery at the University of Missouri-Columbia Department of Surgery.

Exclusion Criteria

  • Women who are perimenopausal. Women who are on Hormone Replacement Therapy.

Outcomes

Primary Outcomes

TNFa

Time Frame: measured in the one sample collected at surgery

TNFa

Il-6

Time Frame: measured in the one sample collected at surgery

Il-6

macrophage

Time Frame: measured in the one sample collected at surgery

macrophage

Study Sites (1)

Loading locations...

Similar Trials